Merck KGaA, Darmstadt, Germany /
Silence Therapeutics plc
Merck KGaA to acquire Silence Therapeutics plc
What happened
Merck KGaA, Darmstadt, Germany agreed to acquire Silence Therapeutics plc through a scheme of arrangement, subject to the conditions in the transaction agreement.
Silence Therapeutics plc shareholders will receive $6.6667 in cash for each ordinary share. Holders of American Depositary Shares will receive $20.00 in cash for each ADS.
The source
Everything on this page comes from the source below.
Merck KGaA to acquire Silence Therapeutics plc
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly